Aurora Cannabis (ACB) Share-based Compensation (2017 - 2025)
Aurora Cannabis (ACB) posted quarterly Share-based Compensation of $1.7 million for Q1 2025, down 26.21% year-on-year from $2.2 million in Q1 2024, and up 39.83% on a QoQ basis from $1.2 million in Q4 2024.
Aurora Cannabis (ACB) Share-based Compensation (2017 - 2025) Analysis & Trends
Aurora Cannabis (ACB) has reported Share-based Compensation for 9 consecutive years, with $1.7 million the latest figure, recorded in Q1 2025.
- Quarterly Share-based Compensation fell 26.21% year-over-year to $1.7 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $8.3 million (down 46.49% YoY) and the FY2026 annual result came in at $5.3 million, down 36.34% from the prior year.
- Share-based Compensation rose to $1.7 million in Q1 2025 per ACB's latest filing, from $1.2 million in the prior quarter.
- Over the last five years, Share-based Compensation for ACB reached as high as $7.8 million in Q4 2022 and fell as low as $1.2 million in Q4 2024.
- A 5-year average of $3.0 million and a median of $2.7 million in 2022 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2022 — Share-based Compensation surged 153.81% — and 2023, when it plunged 73.34%.
- Year by year, Share-based Compensation stood at $3.1 million in 2021, then jumped by 153.81% to $7.8 million in 2022, then tumbled by 73.34% to $2.1 million in 2023, then tumbled by 43.12% to $1.2 million in 2024, then soared by 39.83% to $1.7 million in 2025.
- According to Business Quant data, Share-based Compensation over the past three periods registered $1.7 million, $1.2 million, and $3.3 million for Q1 2025, Q4 2024, and Q3 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 43.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 25.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 125.69 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 58.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 56.50 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 55.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.00 Mn |
| 10 | Aurora Cannabis | 1.11 Bn | 1.03 Bn | 21.72 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 1.66 Mn |
| Mar 31, 2025 | 1.66 Mn |
| Dec 31, 2024 | 1.19 Mn |
| Dec 31, 2024 | 1.19 Mn |
| Sep 30, 2024 | 3.28 Mn |
| Sep 30, 2024 | 3.28 Mn |
| Jun 30, 2024 | 2.21 Mn |
| Jun 30, 2024 | 2.21 Mn |
| Mar 31, 2024 | 2.25 Mn |
| Mar 31, 2024 | 2.25 Mn |
| Dec 31, 2023 | 2.09 Mn |
| Dec 31, 2023 | 2.09 Mn |
| Sep 30, 2023 | 3.41 Mn |
| Sep 30, 2023 | 3.41 Mn |
| Dec 31, 2022 | 7.82 Mn |
| Dec 31, 2022 | 7.82 Mn |
| Sep 30, 2022 | 4.86 Mn |
| Sep 30, 2022 | 4.86 Mn |
| Jun 30, 2022 | 2.72 Mn |
| Jun 30, 2022 | 2.72 Mn |